FindTrial
Sign In

Study on a New Method of VMAT Dose Verification for Nasopharyngeal Carcinoma Based on Multimodal Feature Coupled Diffusion Model

Study on a New Method of VMAT Dose Verification for Nasopharyngeal Carcinoma Based on Multimodal Feature Coupled Diffusion Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113952
Enrollment
Unknown
Registered
2025-12-04
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma, as a highly prevalent malignant tumor in China (approximately 50% of global cases are concentrated in China), has a deep anatomical location and is adjacent to key organs such as the optic nerve and brainstem, making surgery extremely difficult. This leads to about 95% of patients relying on radiotherapy [1]. Volumetric rotational intensity-modulated radiotherapy (VMAT),

Interventions

Case series:no

Sponsors

Jiangxi Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.VMAT radiotherapy for nasopharyngeal carcinoma patients;

Exclusion criteria

Exclusion criteria: 1.no;

Design outcomes

Primary

MeasureTime frame
Gamma pass rate;—

Countries

China

Contacts

Public ContactChangfei Gong

Jiangxi Cancer Hospital

gongcf1990@outlook.com+86 182 7919 2058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026